Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic activity of a hematopoietic stem cell-delivered cell-penetrating frataxin in Friedreich's ataxia models.

Cell reports. Medicine·2026
Same author

Very early [<sup>18</sup>F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trial.

The Lancet. Haematology·2026
Same author

Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same author

Quantification of fractional tumor burden for the early detection of post-treatment glioblastoma progression.

European radiology experimental·2026
Same author

Long-term efficacy and safety results of betibeglogene autotemcel gene therapy for transfusion-dependent β-thalassemia.

Blood·2026
Same author

Lentiviral Gene Therapy for Severe Leukocyte Adhesion Deficiency Type 1.

Obstetrical & gynecological survey·2025
Same journal

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Neonatal systemic gene therapy restores cardiorespiratory function in a rat model of Pompe disease.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Endothelial injury with capillary leak: A final common pathway in acute AAV toxicity?

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Nox1/4 inhibitor Setanaxib treatment ameliorates cardiac function in mouse models of Duchenne Muscular Dystrophy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

HSP90α-USP7-DNMT1 Axis Drives Hepatocellular Carcinoma Recurrence After Microwave Ablation by Disrupting ACSS3-Mediated Propionate Metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
See all related articles

Related Experiment Video

Updated: Jun 4, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Lentiviral vector integration profiles differ in rodent postmitotic tissues.

Cynthia C Bartholomae1, Anne Arens, Kamaljit S Balaggan

  • 1Department of Translational Oncology, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|March 3, 2011
PubMed
Summary
This summary is machine-generated.

Self-inactivating lentiviral vectors show distinct integration preferences in dividing versus postmitotic cells. This finding is crucial for assessing biosafety and optimizing gene therapy for postmitotic tissues.

More Related Videos

Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders
10:21

Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders

Published on: October 7, 2018

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue&#45;Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Jun 4, 2026

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow
12:53

Bidirectional Retroviral Integration Site PCR Methodology and Quantitative Data Analysis Workflow

Published on: June 14, 2017

Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders
10:21

Lentiviral Mediated Production of Transgenic Mice: A Simple and Highly Efficient Method for Direct Study of Founders

Published on: October 7, 2018

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue&#45;Resident Macrophages In Vivo in Mice
06:33

Lentiviral Vector Preparation for Efficient Gene and MicroRNA Modulation of Peritoneal Cavity Tissue-Resident Macrophages In Vivo in Mice

Published on: February 16, 2024

Area of Science:

  • Gene Therapy
  • Molecular Biology
  • Virology

Background:

  • Self-inactivating lentiviral vectors (SIN LTRs) offer sustained transgene expression in various cell types.
  • Genome organization and transcriptional activity differ significantly between dividing and postmitotic cells.
  • Understanding lentiviral integration site preferences is key for safe gene therapy.

Purpose of the Study:

  • To investigate if lentiviral vector integration site (IS) preferences differ between dividing and postmitotic cells.
  • To explore potential mechanisms underlying these integration differences.
  • To assess the suitability of lentiviral vectors for gene transfer into postmitotic tissues.

Main Methods:

  • Integration site (IS) analyses were performed on mouse dividing cells (fibroblasts, HPCs) transduced ex vivo.
  • IS analyses were conducted on mouse postmitotic cells (eye, brain) transduced in vivo.
  • Mechanisms, including Psip1 expression and DNA motifs, were studied to explain observed integration patterns.

Main Results:

  • Dividing cells showed preferential lentiviral integration into gene coding regions.
  • Postmitotic cells exhibited near-random integration into genes and favored gene-sparse LINE elements.
  • Lowered Psip1 expression in postmitotic cells may reduce integration into coding regions; TGGAA motif may favor Satellite DNA integration.

Conclusions:

  • Lentiviral vector integration site preferences are state-dependent, differing between dividing and postmitotic cells.
  • These findings are critical for accurate preclinical biosafety assessments.
  • Lentiviral vectors are suitable for safe and effective gene transfer into postmitotic tissues.